SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-083084
Filing Date
2023-07-21
Accepted
2023-07-21 16:41:16
Documents
15
Period of Report
2023-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2321697d1_8k.htm   iXBRL 8-K 32633
2 EXHIBIT 1.1 tm2321697d1_ex1-1.htm EX-1.1 278035
3 EXHIBIT 5.1 tm2321697d1_ex5-1.htm EX-5.1 14230
7 GRAPHIC tm2321697d1_ex5-1img001.jpg GRAPHIC 4467
  Complete submission text file 0001104659-23-083084.txt   577396

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hepa-20230721.xsd EX-101.SCH 3009
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hepa-20230721_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hepa-20230721_pre.xml EX-101.PRE 22355
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2321697d1_8k_htm.xml XML 3326
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 231102963
SIC: 2834 Pharmaceutical Preparations